What is Wolf-Hirschhorn syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wolf-Hirschhorn Syndrome

Wolf-Hirschhorn syndrome (WHS) is a rare chromosomal disorder caused by deletion of the distal short arm of chromosome 4 (4p16.3), characterized by profound growth retardation, intellectual disability, distinctive facial dysmorphism resembling a "Greek warrior helmet," and seizures. 1, 2

Genetic Basis

  • WHS results from hemizygous deletion of chromosome 4p16.3, with the NSD2 gene (also called WHSC1) being deleted in every case and considered essential for pathogenesis 3, 4
  • The severity and spectrum of features depend on the size and extent of the deletion, functioning as a contiguous gene syndrome where multiple genes contribute to the full phenotype 3, 4
  • Most cases arise from de novo deletions, though the mechanism can vary 1, 2
  • NSD2 haploinsufficiency alone produces a milder phenotype with intellectual disability and facial features but typically without seizures, representing an atypical or partial WHS presentation 3

Core Clinical Features (Present in >75% of Cases)

Growth and Development

  • Intrauterine growth retardation occurs in many but not all cases 1, 5
  • Postnatal growth failure is a constant feature, with profound growth retardation persisting throughout life 1, 2
  • Psychomotor delay and intellectual disability affect 95% of patients, ranging from severe mental deficiency to milder developmental delay depending on deletion size 1, 2, 5

Neurological Manifestations

  • Seizures are a hallmark feature of classic WHS, typically beginning in the neonatal or early infantile period 1, 2, 5
  • Congenital hypotonia is nearly universal, present in approximately 80% of cases 1, 5
  • Microcephaly occurs in one-third of affected individuals 5

Distinctive Facial Dysmorphism ("Greek Warrior Helmet" Appearance)

  • High frontal hairline with prominent forehead and bitemporal narrowness 1, 5
  • Hypertelorism (widely spaced eyes) with upslanting palpebral fissures 3, 5
  • Prominent glabella creating the characteristic "Greek warrior helmet" appearance 2, 5
  • Broad or beaked nose 1
  • Micrognathia and full lips 3, 5

Variable Associated Features

Midline Fusion Defects

  • Cleft lip and/or cleft palate occur with variable frequency 2, 5
  • Cardiac septal defects (ventricular or atrial) are common but not universal 1, 3, 5

Skeletal Abnormalities

  • Clinodactyly and syndactyly may be present 3
  • Hypoplastic cervical vertebrae have been reported 5
  • Classic WHS displays more severe skeletal abnormalities compared to isolated NSD2 deletions 3

Other Organ System Involvement

  • Renal anomalies including dysplastic kidneys, renal cysts, or structural defects should be actively sought as they represent rare but important manifestations 1, 5
  • Structural brain abnormalities including partial or complete agenesis of corpus callosum occur in some cases 1, 5
  • Coloboma of the iris has been described 5
  • Immunodeficiencies represent rare manifestations that warrant evaluation 1
  • Cryptorchidism and genital abnormalities may occur 3

Diagnostic Approach

Clinical Recognition

  • Suspect WHS in any infant with the combination of growth retardation, characteristic facial dysmorphism, hypotonia, and seizures 1, 2, 5
  • The absence of seizures should prompt consideration of NSD2 haploinsufficiency rather than classic WHS, particularly if skeletal abnormalities are mild 3

Genetic Confirmation

  • Chromosomal microarray analysis (CMA) is the current standard diagnostic test for detecting 4p deletions 1
  • Multiplex ligation-dependent probe amplification (MLPA) serves as a reliable and cost-effective screening method, with positive cases requiring confirmation by CMA or karyotype 1
  • Standard karyotype analysis can detect larger deletions but may miss smaller, cryptic deletions 1, 2
  • Whole genome or exome sequencing identifies point mutations in NSD2 in cases with atypical presentations 3

Essential Evaluations Once Diagnosis Suspected

  • Echocardiography to detect cardiac septal defects or other structural heart disease 1, 3, 5
  • Renal ultrasound to identify dysplastic kidneys, cysts, or structural anomalies 1, 5
  • Brain MRI to evaluate for corpus callosum abnormalities and other structural defects 1, 5
  • Ophthalmologic examination for coloboma and other eye abnormalities 5
  • Immunologic evaluation given the risk of immunodeficiency 1

Prognostic Considerations

  • Phenotypic severity correlates with deletion size, with larger deletions producing more severe manifestations 1, 4
  • Patients with isolated NSD2 mutations display milder intellectual disability, absence of seizures, and less severe skeletal involvement compared to classic WHS 3
  • The presence of seizures, cardiac defects, and renal anomalies significantly impacts long-term morbidity 1, 5

Genetic Counseling Implications

  • Medical genetics evaluation is essential to discuss clinical manifestations, natural history, and recurrence risks for parents and family members 1, 5
  • Most cases are de novo, but parental chromosomal analysis may be warranted to exclude balanced translocations 5
  • Prenatal diagnosis is important given the broad spectrum of morphologic abnormalities and inevitable intellectual disability 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.